This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Mouse HGF DuoSet ELISA
catalog :
DY2207
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 11
| Reference |
|---|
Wu Y, Li Y, Matsushima K, Baba T, Mukaida N. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol. 2008;181:6384-93 pubmed
|
Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci U S A. 2007;104:17081-6 pubmed
|
product information
master code :
DY2207
SKU :
DY2207
product name :
Mouse HGF DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Mouse HGF DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies mouse HGF.
target :
HGF
category :
ELISAs
species :
Mouse
gene symbol :
Hgf
kit type :
Solid Phase Sandwich ELISA
elisaRange :
156.00 - 10000 pg/mL
top caption :
Mouse HGF ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
questions and comments
